PACIRA BIOSCIENCES, INC. Deferred Tax Assets, Operating Loss Carryforwards
PACIRA BIOSCIENCES, INC. (PCRX) had Deferred Tax Assets, Operating Loss Carryforwards of $120.28 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $120.28M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $124.54M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $132.26M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $151.50M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $120.28M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $124.54M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $132.26M 10-K · filed 2025-02-27 | |
| 2022-12-31 | $151.50M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $174.20M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $66.12M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $66.26M 10-Q · filed 2020-10-30 | |
| 2019-12-31 | $68.92M 10-K · filed 2021-03-01 | $66.64M 10-K · filed 2020-02-21 |
| 2018-12-31 | $79.45M 10-K · filed 2020-02-21 | |
| 2017-12-31 | $95.07M 10-K · filed 2019-02-28 | |
| 2016-12-31 | $96.16M 10-K · filed 2018-02-28 | |
| 2015-12-31 | $101.01M 10-K · filed 2017-03-01 | |
| 2014-12-31 | $111.09M 10-K · filed 2016-02-25 | |
| 2013-12-31 | $114.82M 10-K · filed 2015-02-24 | |
| 2012-12-31 | $89.15M 10-K · filed 2014-02-25 | |
| 2011-12-31 | $62.23M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |